Abstract
Genome-wide association studies (GWAS) and family-based studies have revealed partly overlapping genetic architectures between various psychiatric disorders. Given clinical overlap between disorders, our knowledge of the genetic architectures underlying specific symptom profiles and risk factors is limited. Here, we aimed to derive distinct profiles relevant to mental health in healthy individuals and to study how these genetically relate to each other and to common psychiatric disorders. Using independent component analysis, we decomposed self-report mental health questionnaires from 136,678 healthy individuals of the UK Biobank, excluding data from individuals with a diagnosed neurological or psychiatric disorder, into thirteen distinct profiles relevant to mental health, capturing different symptoms as well as social and risk factors underlying reduced mental health. Utilizing genotypes from 117,611 of those individuals with White English ancestry, we performed GWAS for each mental health profile and assessed genetic correlations between these profiles, and between the profiles and common psychiatric disorders and cognitive traits. We found that mental health profiles were genetically correlated with a wide range of psychiatric disorders and cognitive traits, with strongest effects typically observed between a given mental health profile and a disorder for which the profile is common (e.g. depression symptoms and major depressive disorder, psychosis and schizophrenia). Strikingly, although the profiles were phenotypically uncorrelated, many of them were genetically correlated with each other. This study provides evidence that statistically independent mental health profiles partly share genetic underpinnings and show genetic overlaps with psychiatric disorders, suggesting that shared genetics across psychiatric disorders cannot be exclusively attributed to the known overlapping symptomatology between the disorders.
Competing Interest Statement
D.R., D.A., O.F., D.vd.M., O.B.S., L.T.W. and T.K. declare no conflicts of interest. O.A.A. is a consultant to HealthLytix and received speakers honorarium from Lundbeck.
Funding Statement
The authors were funded by the Research Council of Norway (#276082 LifespanHealth, #223273 NORMENT, #283798 ERA-NET Neuron SYNSCHIZ, #249795), the South-East Norway Regional Health Authority (2019101, 2019107, and 2020086), and the European Research Council under the European Union's Horizon2020 Research and Innovation program (ERC Starting Grant #802998), as well as the Horizon2020 Research and Innovation Action Grant CoMorMent (#847776).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Code and GWAS summary statistics will be made publicly available via GitHub (github.com/norment) upon acceptance of the manuscript. Furthermore, the derived independent components (individual level data) will be made available to the UK Biobank upon acceptance (derived variable return) to allow its use in future UK Biobank studies.
